These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1393685)

  • 1. Nonspecific immunostimulation with low doses of cyclophosphamide (LDCY), thymostimulin, and Echinacea purpurea extracts (echinacin) in patients with far advanced colorectal cancers: preliminary results.
    Lersch C; Zeuner M; Bauer A; Siemens M; Hart R; Drescher M; Fink U; Dancygier H; Classen M
    Cancer Invest; 1992; 10(5):343-8. PubMed ID: 1393685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of the immune response in outpatients with hepatocellular carcinomas by low doses of cyclophosphamide (LDCY), echinacea purpurea extracts (Echinacin) and thymostimulin.
    Lersch C; Zeuner M; Bauer A; Siebenrock K; Hart R; Wagner F; Fink U; Dancygier H; Classen M
    Arch Geschwulstforsch; 1990; 60(5):379-83. PubMed ID: 2173516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thymostimulin on chemotherapy-induced toxicity and long-term survival in small cell lung cancer patients.
    Macchiarini P; Danesi R; Del Tacca M; Angeletti CA
    Anticancer Res; 1989; 9(1):193-6. PubMed ID: 2539772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical application of extracts of Echinacea purpurea or Echinacea pallida. Critical evaluation of controlled clinical studies].
    Dorsch W
    Z Arztl Fortbild (Jena); 1996 Apr; 90(2):117-22. PubMed ID: 8686334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunostimulation in heart surgery: thymostimulin. Preliminary data].
    Maccherini M; Davoli G; Sani G; Miraldi F; Gotti G; Toscano M
    Minerva Chir; 1993 Dec; 48(23-24):1445-8. PubMed ID: 8177449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of non-specific immunostimulants (echinacin, isoprinosine and thymus factors) on the infection and antigen expression in herpesvirus-6 exposed human lymphoid cells.
    Eichler F; Krueger GR
    In Vivo; 1994; 8(4):565-75. PubMed ID: 7534493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy and thymostimulin in the treatment of advanced-stage breast neoplasms].
    Negri L; Calabrese F; Correggia F; Miozzo S; Giacomasso S
    Minerva Med; 1992 May; 83(5):283-8. PubMed ID: 1589133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunotherapy with high-dose thymostimulin in patients with advanced neoplasms].
    Marcellino LR; Stellato L; Franchi F; Bandini M; Ceccarelli P; Agatensi L
    G Ital Oncol; 1988; 8(1):45-7. PubMed ID: 3220512
    [No Abstract]   [Full Text] [Related]  

  • 9. [Perioperative treatment with thymostimulin in patients with stomach and colorectal neoplasms. Our experience with 114 cases].
    Ciconi E; Capoluongo R; Balduzzi GF; Balzaretti F; Orecchia C
    Minerva Chir; 1992 May; 47(10):939-40. PubMed ID: 1630687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First experience with immunomodulation in septic shock.
    Josten C; Muhr G; Sistermann R
    Prog Clin Biol Res; 1989; 308():989-94. PubMed ID: 2528747
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effects of thymostimulin in a protocol of concurrent hyperfractionated carboplatin and irradiation].
    De Serdio JL; Villar A; Alvarez IE; Gil-Cubelo JA; Suñer M; Hernández R; López-Aguado D
    Acta Otorrinolaringol Esp; 1997; 48(6):487-92. PubMed ID: 9471197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood lymphocyte changes after benign gastrointestinal surgery. Role of thymostimulin in reversing the postoperative immunodepression seen in humans.
    Garcia-Valdecasas JC; Martinez A; Lopoez-Boado MA; de Lacy AM; Cugat E; Grande L; Fuster J; Visa J; Pera C
    Hepatogastroenterology; 1988 Oct; 35(5):219-22. PubMed ID: 2976389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer.
    Weihrauch MR; Ansén S; Jurkiewicz E; Geisen C; Xia Z; Anderson KS; Gracien E; Schmidt M; Wittig B; Diehl V; Wolf J; Bohlen H; Nadler LM
    Clin Cancer Res; 2005 Aug; 11(16):5993-6001. PubMed ID: 16115944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo-controlled trial of thymostimulin in symptomatic HIV-infected patients.
    Beall G; Kruger S; Morales F; Imagawa D; Goldsmith JA; Fisher D; Steinberg J; Phair J; Whaling S; Bitran J
    AIDS; 1990 Jul; 4(7):679-81. PubMed ID: 1975746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial response of metastatic hepatocellular carcinoma after treatment with thymostimulin.
    Palmieri G; Gridelli C; Pepe R; Airoma G; Iaffaioli RV; Frasci G; Caponigro F; Bianco AR
    Tumori; 1990 Feb; 76(1):61-3. PubMed ID: 2157309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effectiveness of thymus preparations (T-activin, thymalin) in erysipelas infection].
    Frolov VM; Peresadin NA; Pustovoĭ IuG; Gaĭdash IS; Tishchenko NA; Gavrilova LA; Pinskiĭ LL
    Sov Med; 1990; (6):111-3. PubMed ID: 2144365
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunomodulatory effects of alpha interferon and thymostimulin in patients with neoplasias.
    Munno I; Marinaro M; Gesario A; Cannuscio B; Michel Y; Paulling E
    Clin Diagn Lab Immunol; 1995 Jul; 2(4):503-5. PubMed ID: 7583935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemotherapy (thymostimulin/cyclophosphamide) in dogs.
    Montoya JA; Martínez EM; Rodríguez M; Pérez-Cuadrado S
    Br Vet J; 1990; 146(3):249-54. PubMed ID: 2364257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of tactivin and imunofan for the treatment of patients with endometrial carcinoma].
    Venediktova MG
    Eksp Klin Farmakol; 2001; 64(5):46-9. PubMed ID: 11764501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of OKT4+ cells during treatment with thymostimulin in parenteral drug addicts with persistent generalized lymphadenopathy.
    Lazzarin A; Galli M; Moriondo P; Parravicini C; Poli G; Moroni M
    J Clin Lab Immunol; 1986 Jun; 20(2):57-61. PubMed ID: 2942692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.